M.D. Anderson Cancer Center: Peripheral Nervous System Diseases trials
The registry lists 13 Peripheral Nervous System Diseases studies with M.D. Anderson Cancer Center as lead sponsor. 0 are open to participants now and 1 have results posted.
Early Phase 1 2Phase 1 2Phase 2 4Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Acupuncture for Chemo-Induced Peripheral NeuropathyCompletedNCT00891618Phase 2Results posted
- Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot StudyActive, not recruitingNCT05357469Not applicable
- Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic PainCompletedNCT04239976Not applicable
- Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral NeuropathyWithdrawnNCT04135326Early Phase 1
- Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral NeuropathyWithdrawnNCT03436680Not applicable
- Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer PatientsWithdrawnNCT02989129Early Phase 1
- Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesActive, not recruitingNCT02221700Not applicable
- SINF: Peripheral Neuropathy in Cancer SurvivorsWithdrawnNCT02168894Phase 1/2
- Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRGTerminatedNCT01815346Phase 1/2
- Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic PainActive, not recruitingNCT01278225
- Chemotherapy-Induced Peripheral Neuropathy SurveyWithdrawnNCT01016028
- Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerCompletedNCT00112996Phase 3
- Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2